Preventive Cardiology Protocol (Dr. Retzler) | HormoneSynergy® Clinic
AI Overview:
Preventive cardiology at HormoneSynergy® Longevity Medicine is part of a broader, measurement-driven longevity strategy. For many patients, cardiovascular risk is the most important starting point because it can be silent for years. We use advanced biomarkers such as ApoB and Lp(a), metabolic assessment, body composition trends, cardiovascular screening, and longitudinal tracking to guide practical prevention in Portland, Lake Oswego, Oregon, and through nationwide education.
Preventive Cardiology as Part of Comprehensive Longevity Care
At HormoneSynergy® Clinic, we do not treat preventive cardiology as a standalone protocol. We practice comprehensive, measurement-driven longevity medicine, and we focus first on what matters most for long-term health.
For many people, the most important first domino is cardiovascular disease risk. It remains one of the leading drivers of serious health outcomes, and it is often silent for years. That is why our care often begins with cardiovascular risk stratification, then expands into a complete, personalized plan across metabolic health, body composition, hormones, nutrition, sleep, fitness, and resilience.
We serve patients locally in Portland and Lake Oswego, Oregon, and provide broader education nationwide. This page is educational and does not replace individualized medical care.
Medical note: This content is for education only and is not medical advice. Your plan should be individualized based on medical history, exam, appropriate testing, and clinical judgment. If you have active symptoms such as chest pain, shortness of breath, or neurologic symptoms, seek urgent medical care.
How HormoneSynergy® Prioritizes Care
Longevity medicine works best when it is prioritized. Instead of trying to optimize everything at once, we identify the highest-leverage health risks first and then build outward.
- Cardiovascular risk, which is often silent and high consequence
- Metabolic health, including insulin resistance, visceral fat, blood pressure, and lipid patterns
- Body composition and fitness, including lean mass, strength, and aerobic capacity
- Hormone optimization when appropriate and medically contextualized
- Sleep, stress, and recovery, which influence nearly every long-term health trajectory
Preventive cardiology is often the starting point because improving cardiovascular risk can meaningfully improve the odds of a longer, healthier life.
Our Preventive Cardiology Approach
The HormoneSynergy® preventive cardiology framework is not a one-size-fits-all checklist. It is a measurement-driven clinical pathway that helps organize risk, identify upstream drivers, and track whether the plan is actually working over time.
Layer 1: Risk Stratification Beyond Basic Cholesterol
Many cardiovascular events occur in people who were told their cholesterol was normal. A standard lipid panel can be useful, but it does not always show the full risk picture. We often look deeper, especially when there is family history, metabolic dysfunction, elevated inflammation, or unclear risk signals.
- ApoB, which helps estimate atherogenic particle burden
- Lp(a), a largely genetic risk amplifier
- Triglycerides, HDL, and triglyceride-to-HDL ratio
- hs-CRP and inflammatory context
- Blood pressure trends and lifestyle contributors
Layer 2: Metabolic Drivers
Cardiovascular risk is frequently accelerated by metabolic dysfunction. Insulin resistance, visceral fat, blood sugar instability, and sleep disruption can all contribute to lipid changes, vascular inflammation, blood pressure shifts, and long-term cardiometabolic risk.
- Fasting insulin and HOMA-IR when appropriate
- A1c and glycemic stability
- Weight trajectory and visceral fat burden
- Insulin resistance and metabolic syndrome patterns
- Sleep quality, stress load, and recovery capacity
Layer 3: Body Composition Data
We treat visceral fat as a risk accelerator and lean mass as protective. Body composition tracking helps move the conversation beyond body weight and gives us a clearer view of metabolic direction.
- DEXA body composition for visceral fat, lean mass, bone density, and trend monitoring
- SECA body composition testing for practical longitudinal tracking
Layer 4: Precision Nutrition
We do not prescribe diets as ideology. We focus on food quality, metabolic response, and measurable change. Nutrition is adjusted to improve risk signals over time, especially ApoB, triglycerides, insulin resistance, inflammatory markers, body composition, and blood pressure.
- Minimizing ultra-processed foods
- Prioritizing fiber density through vegetables, legumes as tolerated, and whole-food carbohydrate sources when appropriate
- Emphasizing unsaturated fats such as olive oil, nuts, seeds, avocado, and fatty fish
- Using carbohydrate reduction strategically when insulin resistance is present, then confirming direction with labs and body composition data
Layer 5: Strength and Fitness as Cardiovascular Medicine
Strength and cardiorespiratory fitness are not optional extras in longevity medicine. They are core risk modifiers. Lean mass, strength, aerobic capacity, and recovery capacity all influence cardiometabolic resilience.
- Progressive resistance training to protect lean mass
- Cardiorespiratory fitness to support cardiovascular resilience
- Recovery and sleep optimization to support adaptation
Layer 6: Targeted Supplements
Supplements are tools, not substitutes for fundamentals. We use them selectively, align them with clinical goals, and prioritize quality. The goal is not to accumulate more products. The goal is to support the plan when there is a clear reason.
- Omega-3 strategy when appropriate
- Magnesium support for vascular tone, recovery, and cardiometabolic context when indicated
- Fiber and microbiome support when aligned with metabolic goals
- Targeted lipid-support nutraceuticals when clinically appropriate
Layer 7: Medications When Appropriate
HormoneSynergy® is not anti-medication. We are anti-imprecision. If overall risk is higher or biomarker targets are not met with lifestyle alone, evidence-based therapies may be appropriate. The decision is individualized and aligned with benefit, safety, goals, and patient context.
- Statins when risk-based treatment is appropriate
- Ezetimibe as an adjunct when appropriate
- PCSK9 inhibitors for selected higher-risk profiles
- GLP-1 therapies when the metabolic risk phenotype supports them
Layer 8: Longitudinal Tracking
Most prevention plans fail because they are not tracked. We re-check what matters, verify direction, and refine strategy. Prevention is not a one-time recommendation. It is a long-term trajectory built through measurable progress.
- Planned re-checks of key biomarkers
- Body composition trend monitoring
- Cardiovascular screening when appropriate
- Ongoing strategy adjustments based on objective results
Who This Approach Is For
- People with a family history of early heart disease or stroke
- People with elevated ApoB, LDL particle burden, or Lp(a)
- People with insulin resistance, metabolic syndrome, or visceral fat concerns
- Women navigating perimenopause, menopause, or postmenopausal risk changes
- People who want a more complete cardiovascular risk assessment than basic cholesterol alone
- High-performance professionals focused on long-term resilience and prevention
What You’ll Walk Away With
- A prioritized plan focused on your highest-leverage risks first
- Clear targets and next steps based on physiology, not generic ranges alone
- Practical interventions across nutrition, training, recovery, supplements, and medication when appropriate
- A follow-up measurement schedule to confirm progress and refine the plan
Related Longevity Medicine Resources
Preventive cardiology is connected to the broader longevity medicine system. These related resources explain the major risk drivers we often evaluate together.
Frequently Asked Questions
Is this a standalone cardiology program?
No. Preventive cardiology is integrated into our comprehensive longevity approach. We often begin with cardiovascular risk because it can be silent and high-impact, then expand into metabolic health, body composition, hormones when appropriate, and lifestyle foundations.
Why do you prioritize cardiovascular disease first?
Cardiovascular disease remains one of the leading drivers of serious health outcomes, often developing quietly for years. Addressing it early can meaningfully improve long-term health trajectory and reduce downstream risk.
Why do you emphasize ApoB?
ApoB is a useful marker of the number of atherogenic lipoprotein particles. In many people, it helps clarify risk beyond LDL-C alone. We interpret ApoB in context with the full risk profile.
What is Lp(a), and who should test it?
Lp(a) is largely genetic and can amplify cardiovascular risk. Testing is commonly considered for those with family history of early cardiovascular disease or those seeking a more complete risk profile.
If my cholesterol is normal, do I still need advanced testing?
Sometimes. Normal ranges do not always reflect individual risk, especially with family history, insulin resistance, inflammation, or other risk amplifiers. We use a targeted approach based on history, goals, and baseline signals.
Do you recommend low-carb diets for heart health?
We focus on food quality and measurable response, not ideology. For some people with insulin resistance, strategic carbohydrate reduction helps. For others, a different pattern may be better. We tailor the approach and verify direction with labs and trend data.
Why do you track visceral fat and lean mass?
Visceral fat is associated with higher cardiometabolic risk, while lean mass supports metabolic resilience. DEXA or clinical-grade body composition testing helps measure what is changing, not just body weight.
Are supplements enough to reduce cardiovascular risk?
Supplements can be helpful tools, but they do not replace fundamentals like nutrition quality, training, sleep, and metabolic control. We use supplements selectively and align them with goals and biomarkers.
When are medications appropriate?
Medications may be appropriate when overall risk is higher or when targets are not met with lifestyle alone. Decisions are individualized and consider benefit, safety, and patient preferences.
How often do you re-test?
It depends on baseline risk and what is being changed. In general, labs and body composition are re-checked to confirm direction, then the strategy is refined based on objective results.
Location
HormoneSynergy® Clinic
9 Monroe Parkway, Suite 260
Lake Oswego, OR 97035
503-230-7990
Serving Portland and Lake Oswego, Oregon. Educational resources available nationwide.
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →